Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals.
about
Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclidesSynthesis of peptide radiopharmaceuticals for the therapy and diagnosis of tumor diseasesRadiolabeled cyclic RGD peptides as radiotracers for tumor imagingChemotherapy synergizes with radioimmunotherapy targeting La autoantigen in tumorsRadioiodinated hypericin: its biodistribution, necrosis avidity and therapeutic efficacy are influenced by formulation.Development of (153) Sm-folate-polyethyleneimine-conjugated chitosan nanoparticles for targeted therapy.Lanthanide(III) complexes of a mono(methylphosphonate) analogue of H4dota: the influence of protonation of the phosphonate moiety on the TSAP/SAP isomer ratio and the water exchange rate.Metal complexes of cyclen and cyclam derivatives useful for medical applications: a discussion based on thermodynamic stability constants and structural data.Strategies for labeling proteins with PARACEST agentsA New Synthesis of TE2A-a Potential Bifunctional Chelator for (64)Cu.Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of diseaseComparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607.Rational design, synthesis, and evaluation of tetrahydroxamic acid chelators for stable complexation of zirconium(IV)Development of a highly selective cell-permeable ratiometric fluorescent chemosensor for oxorhenium(V) ion.Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands.Impact of multiple negative charges on blood clearance and biodistribution characteristics of 99mTc-labeled dimeric cyclic RGD peptidesUnexpected side products in the conjugation of an amine-derivatized morpholino oligomer with p-isothiocyanate benzyl DTPA and their removal.Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECTSynthesis and characterization of the copper(II) complexes of new N2S2-donor macrocyclic ligands: synthesis and in vivo evaluation of the (64)Cu complexes.Novel Bifunctional Cyclic Chelator for (89)Zr Labeling-Radiolabeling and Targeting Properties of RGD ConjugatesDesign and development of molecular imaging probes.Novel bimodal bifunctional ligands for radioimmunotherapy and targeted MRI.Linker effects on biological properties of 111In-labeled DTPA conjugates of a cyclic RGDfK dimerImpact of PKM linkers on biodistribution characteristics of the 99mTc-labeled cyclic RGDfK dimerThe evolving role of nuclear molecular imaging in cancer.Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals.Evaluation of the pharmacokinetic effects of various linking group using the 111In-DOTA-X-BBN(7-14)NH2 structural paradigm in a prostate cancer model.Synthesis and antimalarial activities of cyclen 4-aminoquinoline analogs.H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapyRadiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency.Radiometallated peptides for molecular imaging and targeted therapy.The synthesis and application of polyamino polycarboxylic bifunctional chelating agents.Nanoprobes for hybrid SPECT/MR molecular imaging.Matching chelators to radiometals for radiopharmaceuticals.Advances in lanthanide-based luminescent peptide probes for monitoring the activity of kinase and phosphatase.Recent advances in chelator design and labelling methodology for (68) Ga radiopharmaceuticals.Radiolabeling strategies for tumor-targeting proteinaceous drugs.Octadentate picolinic acid-based bispidine ligand for radiometal ions.Radiopharmaceuticals for metastatic bone pain palliation: available options in the clinical domain and their comparisons.Final step gallium-68 radiolabelling of silica-coated iron oxide nanorods as potential PET/MR multimodal imaging agents.
P2860
Q24649091-838B5D12-ECCD-42DF-9516-09B087B5B893Q27025187-B3F16829-A690-4D7E-B8FB-B0B68418E63FQ28072021-91C048A8-5FEB-4033-AEE5-49614C8271DCQ28474893-72E365E0-76C9-4BFA-B373-6D87F242731BQ30660860-4327B512-C244-4F04-BF10-AD130FCDEB12Q30963856-99EE38B8-0137-4F9B-8CC4-5153DFFDBF1EQ30981846-CD7EA1E7-C7A3-4160-B611-61DC226224AAQ31116849-DB932633-8098-45E9-B6E5-E614715EC6D1Q33629989-C02A1228-80AD-40FF-B5F6-DDFCE130A9AAQ33704117-F963A879-8A6F-4F46-8B8C-311A0E0923C4Q33870879-E7CA3D54-74EE-4E17-8443-77924101A521Q33884461-EEE59D26-1B3B-4708-97E4-4A4F65BD6F61Q34009558-31AB26B5-3956-46BB-8F77-68593AB9329EQ34039938-AF5D72D5-496D-4096-8784-36F9568DA5ECQ34160678-8E9A8BA7-BF39-4929-BAF4-D9D518E06A08Q34196969-1B8B7DF8-4B8D-4463-B4D2-89F4B7142997Q34644344-A3A07B8B-17A6-4380-BF65-46105AEC5AE6Q34912643-7A5FE57D-CF4E-4BE7-A7F6-C2F34944FD20Q35565660-A363DC58-2F8D-4C55-8B59-2E822B109534Q35676322-ACC1CF2F-AF23-4BEC-A455-01DAEAAFEBEEQ36785137-223AD1CC-81A4-4018-B758-86873397E2B8Q36813571-07A194E2-ABA2-4EAB-9354-354BF059EB08Q36865548-C468EFBC-3118-4859-A0A1-69D9A2948C25Q36924767-1FDE9329-3ABE-48DF-B7E3-C214C0CF3712Q37011086-423DE76B-51AF-41D2-B8FB-3E4758AF11CEQ37026964-AB705C0B-85B0-4727-BB3D-ABAC64E54DF5Q37109589-7ADECB3A-E95B-4DA5-B294-21C8E1D6C2BFQ37144874-9DC7D092-5B4D-426C-A294-8C14AFC4F7F2Q37209655-6135F912-D7CF-42ED-BFD5-2C06158BC2A5Q37480688-11DBFD30-675C-4B08-B915-F3B803786BE6Q37847064-AE00E08D-E174-473E-B55B-F8650F27C4B9Q37850696-E93812E0-68B5-4532-A4A9-B7EECE9C8F80Q38013146-839E3337-C7EC-45AE-9375-90FB0B659874Q38156660-4B1F0711-E15B-42F2-8DFD-C26C25408C0BQ38170053-F09BEAFE-3527-4BDF-82DE-AE6F806F9383Q38185314-8C90F0EA-AB38-4CAB-AFE0-3F0808A8B326Q38189541-BB1B1615-28E3-4A7F-A9CD-E776811396A3Q38620836-718383D4-7195-4584-9060-726CB58E0757Q39042390-455AA715-4285-4B67-AC3A-54B5982FD78AQ39111564-DCA0A7D3-6125-4700-BB7C-7B193865DCB7
P2860
Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals.
@ast
Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals.
@en
Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals.
@nl
type
label
Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals.
@ast
Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals.
@en
Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals.
@nl
prefLabel
Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals.
@ast
Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals.
@en
Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals.
@nl
P356
P1476
Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals.
@en
P2093
P356
10.1021/BC000070V
P577
2001-01-01T00:00:00Z